脊柱外科手术中计算机辅助导航技术应用的初步经验

目的探讨计算机辅助导航技术（computer aided surgery navigation system,CASNS）在脊柱外科手术中的应用价值。方法 2006年2月至2007年6月采用CASNS和传统解剖标志辨认法辅助＂C＂型臂X线机定位行椎弓根螺钉植入术,各分别治疗15例脊柱伤包括脊柱骨折、脊柱侧凸、颈椎肿瘤及退变患者。术后通过CT等影像学检查判断两组内固定术的植钉准确性。结果 CASNS组共植入椎弓根螺钉125枚,其中优114枚（91.2%）,良10枚（8.0%）,差1枚（0.8%）,优良率为99.2%;徒手植钉组共植入椎弓根螺钉129枚,其中优78枚（60.5%）,良32枚（24.8%）,差19枚（14.7%）,优良率为85.3%。结论应用CASNS行脊柱伤椎弓根螺钉植入的准确性明显优于传统解剖标志辨认法辅助＂C＂型臂X线机定位法,CASNS显著提高脊柱外科手术的安全性及矫正效果,在脊柱外科手术中具有极高的应用价值。     

术中三维导航引导下脊柱侧凸的椎弓根螺钉置入研究

[目的]探讨术中实施三维导航在脊柱侧凸病人椎弓根螺钉置入的应用价值.[方法] 38例脊柱侧凸病人行三维导航引导下椎弓根螺钉固定术,其中青少年特发性脊柱侧凸18例,老年退行性脊柱侧凸20例.手术中脊柱CT三维扫描后向导航系统输入患者信息资料,用导航棒按导航指引下在最佳位置、直径和长度立体、动态地置入椎弓根螺钉.[结果]三维导航引导下成功对38例脊柱侧凸病人共置入236枚椎弓根螺钉,复查X线片和CT,无螺钉松动和断裂,按分类法:A级227枚,B级7枚,C级2枚,D级0枚.术后侧凸平均26°(21°～118°),矫正率(61％);术后后凸平均14°(5°～29°),矫正率39％.38例平均随访18个月(12 ～25个月),术后无脊髓或神经根损伤.[结论]三维导航引导下的脊柱侧凸椎弓根钉置入方法精确可靠.     

胸椎椎弓根螺钉在脊柱侧凸矫形术中的应用效果评价

[目的]评价胸椎椎弓根螺钉在脊柱侧凸矫形术中的应用效果。[方法]2008～2010年采用后路胸椎椎弓根螺钉技术治疗特发性和先天性脊柱侧凸患者26例。根据术后临床表现、矫正率和术后X线片判定胸椎椎弓根螺钉置钉情况,对胸椎椎弓根螺钉在脊柱侧凸矫形术中的应用效果进行评价。[结果]本组病例术后平均矫正率为63.81%,术后患者脊柱长度平均增加6.2 cm;术后X线片判定置入的308枚胸椎椎弓根螺钉中,置钉不良率为16.9%;所有患者术后均无胸部脏器及神经系统损伤表现。[结论]在脊柱侧凸临床治疗中,采用胸椎椎弓根螺钉进行侧凸矫形是有效、安全的方式。     

个体化导航模板在胸椎椎弓根螺钉置入中的初步临床应用

目的:通过临床应用评价个体化导航模板辅助胸椎椎弓根螺钉置入的准确性和安全性。方法:2008年7月～2009年9月,对11例需要行胸椎椎弓根螺钉置入手术的患者(青少年特发性脊柱侧凸7例,先天性脊柱侧凸2例,胸椎结核后凸畸形1例,多发性胸椎骨折1例)术前根据CT三维重建图像利用计算机辅助设计及快速成型技术设计制作46个胸椎个体化导航模板,术中应用个体化导航模板辅助在T2～T12置入椎弓根螺钉92枚,术后CT扫描评价螺钉位置,记录有无与螺钉置入相关的并发症。结果:通过个体化导航模板辅助置入的92枚胸椎椎弓根螺钉中,83枚完全在椎弓根内,9枚穿破椎弓根壁(其中椎弓根内侧壁穿破2枚、椎弓根外侧壁穿破7枚),其中5枚螺钉因椎弓根宽度小于4mm(3.0～3.8mm)而采用椎弓根旁固定方法(椎弓根螺钉轻度穿破椎弓根外侧壁经胸肋关节内侧进入椎体),椎弓根壁非故意穿破率为4.3%,置钉准确率为95.7%,所有穿破椎弓根壁的螺钉的穿出距离均小于2mm,螺钉位置可接受率为100%。无与螺钉置入有关的神经、血管、内脏损伤等并发症的发生。结论:个体化导航模板辅助胸椎椎弓根螺钉置入的置钉准确率高,安全、可行。     

O-arm计算机导航辅助脊柱椎弓根螺钉置入的准确性

[目的]分析O-arm计算机辅助导航技术在脊柱椎弓根螺钉置入的准确性。[方法]回顾性分析2017年1月~2018年9月本院椎弓根螺钉置入患者575例,根据椎弓根螺钉置入方式不同,分为两组。导航组采用O-arm计算机辅助导航技术系统置入椎弓根螺钉233例,传统组采用传统徒手法置入椎弓根螺钉342例。行CT检查,依据Neo分型评估置钉准确性。[结果]导航组共置入1459枚椎弓根螺钉,其中C1~7置入222枚,T1~12置入535枚,L1~5置入652枚,S1置入50枚。每名患者置钉数量1~24枚,平均(6.26±3.77)枚。传统组共置入1724枚椎弓根螺钉,其中C1~7置入269枚,T1~12置入601枚,L1~5置入785枚,S1置入87枚。每名患者置钉数量1~20枚,平均(5.67±4.11)枚。导航组全部病例顺利完成手术,术中无血管、神经损伤等并发症,置钉安全率为100%,传统组有4例发生血管、神经损伤等并发症。所有患者术后进行12~24个月随访,随访过程均未发生不良事件。依据CT影像Neo分级标准,导航0型及1型椎弓根螺钉的成功置入率达98.01%,而传统组0型及1型椎弓根螺钉的成功置入率91.85%;两组间置入螺钉准确性的差异具有统计学意义(P<0.05)。[结论]与传统C臂X线机等徒手置钉方式相比,O-arm计算机辅助导航技术可提高脊柱椎弓根螺钉置入准确性,同时降低神经、血管等并发症的发生。     

电磁导航系统结合Stagnara投照法在特发性脊柱侧凸手术中的应用

目的:探讨在特发性脊柱侧凸三维矫形术中应用电磁导航系统结合Stagnara投照法采集C型臂X线透视图像对椎弓根螺钉置入准确性与安全性的影响.方法:2006年4月～2008年12月在电磁导航辅助下行特发性脊柱侧凸三维矫形术47例(导航组),共置入椎弓根螺钉492枚:2004年6月～2006年4月在C型臂X线机透视下行特发性脊柱侧凸三维矫形术39例(透视组),共置入椎弓根螺钉454枚,两组均采用Stagnara投照法采集C型臂X线透视图像.术后行CT薄层平扫加椎弓根矢状面二维重建,通过测量椎弓根皮质外缘与穿出的螺钉边缘的垂直距离对椎弓根螺钉位置进行评价,并分为A、B、C、D级,以A级和B级合并计算优良率.结果:导航组的手术时间为165～420min,平均233.7min,透视组为175～365min.平均236.1min,两组比较无显著性差异(P>0.05);导航组术中出血量为450～1650ml,平均712.2ml.透视组为550～1900ml,平均794.9ml,两组比较有显著性差异(P<0.05).导航组术后椎弓根螺钉位置A级476枚,B级9枚,C级5枚,D级2枚,优良率为98.5%;透视组A级411枚,B级14枚,C级17枚,D级12枚,优良率为93.6%,两组置钉优良率比较有显著性差异(P<0.05).导航组无神经、血管并发症发生.透视组2例在术中发生螺钉损伤硬膜囊,1例术后发现螺钉刺激神经根.结论:在特发性脊柱侧凸三维矫形术中应用电磁导航系统结合Stagnara投照法采集C型臂X线透视图像可降低椎弓根螺钉的误置率,减少术中出血量,提高手术安全性.     

青少年脊柱侧凸患者胸椎椎弓根螺钉置入的准确性和安全性评价

目的：探讨青少年脊柱侧凸患者胸椎椎弓根螺钉置入的准确性和安全性，以减少相关手术并发症。方法：32例青少年脊柱侧凸患者术前均对畸形脊柱进行标准俯卧位CT加密扫描，测量进钉点至椎体前缘的深度、进针角度、椎弓根直径和椎体的旋转角度，根据测得数据确定椎弓根螺钉置入的深度和方向，置入螺钉后再行脊柱全长X线片及CT扫描评价置钉的准确性和安全性。结果：32例共置入226枚胸椎椎弓根螺钉，术后CT加密和X线片观察到205枚螺钉（90．7％）完全在椎弓根皮质骨内。10例21枚螺钉（9.3％）发生错置，7枚螺钉（3．1％）偏外，5枚螺钉（2．2％）偏前外侧（其中2枚螺钉靠近节段血管），4枚螺钉（1．8％）偏下，4枚螺钉（1．8％）直径过大导致椎弓根内壁膨胀内移，1枚螺钉（0．4％）误入椎管导致完全性脊髓损伤。T1～T4错置12枚（18．2％），T5～T12错置9枚（6．1％）；凸侧椎根螺钉置入的准确率为93．8％，凹侧为83．1％。结论：脊柱畸形患者术前应常规采用标准俯卧位CT加密扫描，根据扫描图像测得的相关数据可为术中准确置入椎弓根螺钉提供重要参考依据。在青少年脊柱侧凸患者胸椎椎弓根螺钉置入有一定的误置率，螺钉发生错置多见于上胸椎和凹侧．术中应高度重视。     

计算机导航辅助椎弓根螺钉后路固定在骨质疏松患者中的临床应用

目的探讨计算机导航辅助椎弓根螺钉植入在骨质疏松患者脊柱后路固定手术中的应用效果。方法 2009年12月-2011年3月,使用计算机导航辅助椎弓根螺钉固定技术治疗合并骨质疏松症患者51例(导航组),与同期传统X线机监视下徒手植入椎弓根螺钉治疗该类患者41例(传统组)进行比较。术前经双能骨密度测量两组均合并骨质疏松症。两组患者性别、年龄、骨密度测定值、病程、累及节段、术前合并症等一般资料比较差异无统计学意义(P>0.05),具有可比性。记录两组患者术中出血量、手术时间、螺钉重植率以及术后并发症等情况。术后通过CT采用Richter法评价椎弓根螺钉位置,通过三维CT评价植骨融合情况。结果导航组植入螺钉250枚,其中初植成功239枚,螺钉重植11枚(4.4%);传统组植入螺钉213枚,其中初植成功190枚,螺钉重植23枚(10.8%);两组螺钉重植率比较差异有统计学意义(χ~2=6.919,P=0.009)。导航组手术时间及术中出血量均少于传统组(P<0.05)。Richter法评价椎弓根螺钉位置,导航组优240枚、良10枚,传统组优191枚、良21枚、差1枚,两组差异有统计学意义(χ~2=7.566,P=0.023)。导航组和传统组随访时间分别为(7.8±1.5)个月和(8.7±1.5)个月。导航组术后6个月三维CT显示植骨均达骨性融合,未发现椎弓根螺钉松动、拔出、断裂等情况。传统组1例术后6个月植骨部分吸收,给予支具制动限制活动,加强抗骨质疏松治疗等措施,术后9个月植骨达骨性融合;余患者术后6个月植骨达骨性融合。结论计算机导航技术能够很大程度避免椎弓根螺钉位置偏差、反复拔出重植等情况,实现每枚椎弓根螺钉最大稳定性,减少手术暴露时间及出血量,为合并有骨质疏松症患者行脊柱后路固定手术提供了一种简便、有效的手术辅助方式。     

导航辅助脊柱胸腰段椎弓根钉植入的临床应用

目的探讨临床运用计算机影像导航技术引导脊柱胸腰段椎弓根钉植入的准确性。方法2003年5月-2007年5月，29例患者接受116枚计算机影像导航技术引导脊柱胸腰段椎弓根钉植入手术治疗，T10-T1250枚胸椎弓根钉，L1-L3 66枚腰椎弓根钉。术中记录椎弓根钉植入所需时间及C-臂透视工作次数，椎弓根钉植入完成后，即行C-臂正侧位摄片并与导航路径进行比较测量。术后CT进行椎弓根层面扫描，根据椎弓根钉与椎弓根皮质问关系分为四级：A=在椎弓根内；B=突破皮质，〈2mm；C=突破皮质，2-4mm；C=突破皮质，〉4mm。结果术后CT椎弓根位置扫描显示：A级101枚（87．07％）；B级10枚（8．62％）；C级2枚（1．72％）；D级3枚（2．59％）。1枚椎弓根钉植入平均所需时间：2．73±0．64min（1．15～4．02min）。下胸椎9枚（7．75％）胸椎弓根钉突破皮质，上腰椎6枚（5．17％）腰椎弓根钉突破皮质，且临床观察未发现与椎弓根钉突破皮质相关的神经血管等并发症。植入的椎弓根钉C-臂正侧位摄片与导航路径吻合比较，进钉点均差2．6mm（最大3．1mm），角度均差3．3°（最大5．4°）。结论计算机影像导航辅助脊柱胸腰段椎弓根钉植入，提供二维、多平面实时显示，保证了脊柱胸腰段椎弓根钉植入的准确性及安全性，明显减少放射线的暴露强度。     

非影像监视下行脊柱侧凸胸椎椎弓根螺钉置入的临床应用

目的:探讨脊柱侧凸胸椎椎弓根螺钉非影像监视下徒手置入的方法及可行性。方法:57例脊柱侧凸患者行后路椎弓根螺钉系统矫形手术,徒手法置入胸椎椎弓根螺钉。术后常规拍摄脊柱全长X线片,随机选取10例患者行CT扫描观察,了解螺钉置入的准确性。结果:共置入胸椎椎弓根螺钉362枚。术后X线片观察到10枚螺钉偏外,4枚螺钉偏下,其中2枚螺钉引起轻微肋间神经痛,3周后完全缓解。CT观察47枚螺钉有2枚螺钉导致椎弓根内壁膨胀内移,没有相应神经症状。主弯Cobb角术前平均60.4°(32°～121°),术后平均18.3°(1°～70°),平均矫正率71.9%(38.1%～98.0%)。结论:徒手法置入脊柱侧凸胸椎椎弓根螺钉是可行的。     

Vasopressor hormone response following mesenteric traction during major abdominal surgery

Background : We investigated the vasopressor hormone response following mesenteric traction (MT) with hypotension due to prostacyclin (PGI₂) release in patients undergoing abdominal surgery with a combined general and epidural anesthesia. Methods : In a prospective, randomized, placebo-controlled study we administered 400 mg ibuprofen (i.v.) in 42 patients scheduled for abdominal surgery. General anesthesia was combined with epidural anesthesia (T4-L1). Before as well as 5, 15, 30, 45, and 90 min after MT we recorded plasma osmolality, hemodynamics and measured 6-keto-PGFlα (stabile metabolite of PGI₂), TXB₂ (stabile metabolite of thromboxane A₂) active renin, and arginine vasopressin (AVP) plasma concentrations by radioimmunoassay. Catecholamine levels were assessed by high-pressure liquid chromatography (HPLC) with electrochemical detection. Results : Following MT, arterial hypotension occurred along with a substantial PGI₂ release. This was completely abolished by ibuprofen administration. Although plasma levels of 6-keto-PGF_1α (1133 (708) vs. 60 (3) ng/L, median (median absolute deviation), P=0.0001, placebo vs. ibuprofen) remained significantly elevated, blood pressure was restored within 30 min after MT in the placebo group. At the same point in time plasma concentrations of TXB² (164 (87) vs. 58 (1) ng/L, P=0.0001), epinephrine (46 (33) vs. 14 (6) ng/L, P=0.001), AVP (41 ± (18) vs. 12 (7) ng/L, P=0.0004), and active renin (27 (12) vs. 12 (4) ng/L, P = 0.001) were significantly higher in placebo-treated patients. Conclusion : Under combined general and epidural anesthesia arterial hypotension following MT due to endogenous PGI₂ release is associated with enhanced release of AVP, active renin, epinephrine and thromboxane A₂, presumably contributing to hemodynamic stability within 30 min after MT.     

A Teaspoon Pump for Pumping Blood with High Hydraulic Efficiency and Low Hemolysis Potential

Abstract: Virtually all blood pumps contain some kind of rubbing, sliding, closely moving machinery surfaces that are exposed to the blood being pumped. These valves, internal bearings, magnetic bearing position sensors, and shaft seals cause most of the problems with blood pumps. The original teaspoon pump design prevented the rubbing, sliding machinery surfaces from contacting the blood. However, the hydraulic efficiency was low because the blood was able to "slip around" the rotating impeller so that the blood itself never rotated fast enough to develop adequate pressure. An improved teaspoon blood pump has been designed and tested and has shown acceptable hydraulic performance and low hemolysis potential. The new pump uses a nonrotating "swinging" hose as the pump impeller. The fluid enters the pump through the center of the swinging hose; therefore, there can be no fluid slip between the revolving blood and the revolving impeller. The new pump uses an impeller that is comparable to a flexible garden hose. If the free end of the hose were swung around in a circle like half of a jump rope, the fluid inside the hose would rotate and develop pressure even though the hose impeller itself did not "rotate"; therefore, no rotating shaft seal or internal bearings are required.     

Microspheres Based Detoxification System: A New Method in Convective Blood Purification

Abstract: A variety of protein-bound or hydrophobic substances, accumulating as a result of pathologic conditions such as exogenous or endogenous intoxications, are removed poorly by conventional detoxification methods because of low accessibility (hemodialysis), insufficient adsorption capabilities (hemosorption), low efficiency (peritoneal dialysis), or economic limitations (high-volume plasmapheresis). Combining advantages of existing methods with microspheric technology, a module-based system was designed. Major operating parameters of the latter can be modified to allow for adjustment to individual clinical situations. An extracorporeal blood circuit including a plasmafilter is combined with a secondary high-velocity plasma circuit driven by a centrifugal pump. Different microspheric adsorbers can be combined in one circuit or applied in sequence. Thus, a prolonged treatment can be tailored using specially designed selective adsorber materials. Comparing this system with existing methods (high-flux hemodialysis, molecular adsorbent recycling system), results from our in vitro studies and animal experiments demonstrate the superior efficiency of substance removal.     

Tissue perfusion in relation to cardiac output during continuous positive-pressure ventilation and administration of propranolol or verapamil

Background : Our objective was to determine whether administration of propranolol or verapamil modifies the hemodynamic adaptation to continuous positive-pressure ventilation (CPPV), in particular the regional distribution of cardiac output (CO).
Methods : General hemodynamics and regional blood flows assessed by microsphere technique (15 (μm) were recorded in 16 anesthetized pigs during spontaneous breathing (SB) and CPPV with 8 cm H₂O end-expiratory pressure (CPPV8) before and after intravenous administration of propranolol (0.3 mg · kg⁻¹ followed by 0.15 mg · kg⁻¹ · h⁻¹, n=8) or verapamil (0.1 mg · kg⁻¹ followed by 0.3 mg · kg⁻¹ · h⁻¹, n=8).
Results : CPPV8 depressed CO by 25% without shifts in its relative distribution with the exception of a noteworthy increase in adrenal perfusion. Propranolol increased arterial blood pressure, and due to a fall in heart rate, CO dropped by 25%. The kidneys and, to a lesser extent, the splanchic region and central nervous system received increased fractions of the remaining CO at the expense of skeletal muscle flow. Similar patterns were seen during SB and CPPV8 such that the combination of propranolol and CPPV8 depressed CO by 50%. The circulatory effects of verapamil were less evident but myocardial perfusion tended to increase.
Conclusions : The combination of propranolol or verapamil with CPPV does not result in any specific hemodynamic interaction in anesthetized pigs, except that the combined effect of propranolol and CPPV may severely reduce CO.     

Bariatric Surgery in Some "Central and East-European (former Eastern bloc)"Countries - Current Status and Prediction for the Next Millennium

Background: Obesity is increasing globallly, including in the formerly "Eastern Bloc" countries. Methods: A survey was made of obesity and bariatric surgery. Results: In the 8 East and Central European countries studied, with total population 300 million, roughly 43% of the population was overweight (BMI 25-30), 23% obese (BMI > 30), with about 15 million people morbidly obese (BMI > 40). From 0-10 morbidly obese individuals/100,000/year undergo bariatric surgery. Conclusion: Most countries were found to provide inadequate treatment for obesity.The majority of the morbidly obese are not treated effectively. However, health-care awareness of obesity and bariatric surgeons are slowly increasing.     

Volatile anaesthetics reduce adhesion of blood platelets under low-flow conditions in the coronary system of isolated guinea pig hearts

Background : Inhibitory effects of volatile anaesthetics on platelet aggregation have been demonstrated in several studies. However, the influence of volatile anaesthetics on intracoronary platelet adhesion has not been elucidated so far.
Methods : Isolated hearts of guinea pigs were perfused with buffer in the absence or presence of volatile anaesthetics (0.5 and 1 MAC) at constant coronary flow rates of 5 ml/min for 25 min, then 1 ml/min for 30 min and again 5 ml/min for 10 min. Before, during and after low-flow perfusion, a bolus of human platelets was applied into the coronary system. To simulate thrombogenic conditions, 0.3 U/ml human thrombin was infused during low-flow perfusion and reperfusion. The number of platelets sequestered to the endothelium was calculated from the difference between coronary in- and output of platelets. The myocardial production of lactate and consumption of pyruvate and coronary perfusion pressure were also determined.
Results : At a flow rate of 5 ml/min only about 3% of the applied platelets did not emerge from the coronary system, in any group. In contrast, 13.1±1.2% (mean±SEM) of infused platelets became adherent in low-flow perfusion in the control group without anaesthetic. The adherence was reduced with each 1 MAC isoflurane (to 6.2±1.2%), sevoflurane (to 4.4±0.9%) or halothane (to 3.2±1.5%) (each P <0.05 vs. control). Volatile anaesthetic, 0.5 MAC, did not inhibit platelet adhesion to a statistically significant extent in any case. Perfusion pressure and metabolic parameters were not statistically different between the control and the hearts exposed to anaesthetics.
Conclusion : Volatile anaesthetics in a concentration of 1 MAC can reduce the adhesion of platelets in the coronary system under reduced flow conditions. This action does not arise from vasodilation or inhibition of ischaemic stress.     

Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits

Background: It has been shown that the depressive effects of both propofol and midazolam on consciousness are synergistic with opioids, but the nature of their interactions on other physiological systems, e. g. respiration, has not been fully investigated. The present study examined the effect of propofol and midazolam alone and in combination with fentanyl on phrenic nerve activity (PNA) and whether such interactions are additive or synergistic. Methods: PNA was recorded in 27 anaesthetised and artificially ventilated rabbits. In three groups, propofol, fentanyl and midazolam were administered intravenously in incremental doses to construct dose-response curves for the depressant effects of each one on PNA. In another two groups, the effect of pretreatment with either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. on the effects of propofol and fentanyl respectively on PNA were studied. Results: Propofol and fentanyl caused a dose-dependent depression of PNA with complete abolition at the highest total doses of 16 mg · kg^?1 i. v. and 32 μg · kg^?1 i. v., respectively. In contrast, midazolam in incremental doses to a total of 0.8 mg · kg^?1 reduced mean PNA by 63%, but approximately 12% of PNA remained at a total dose as high as 6.4 mg · kg^?1. The mean ED₅₀s, calculated from dose-response curves, were 5.4 mg · kg^?1, 3.9 μg · kg^?1 and 0.4 mg · kg^?1 for propofol, fentanyl and midazolam, respectively. Initial doses of either fentanyl 1 μg · kg^?1 i. v. or midazolam 0.05 mg · kg^?1 i. v. acted synergistically with subsequent doses of either propofol or fentanyl to abolish PNA at total doses of 8 mg · kg^?1 and 8 μg · kg^?1, respectively. Conclusion: Fentanyl has a synergistic interaction with both propofol and midazolam on PNA and hence potentially on respiration.     

Influence of dopexamine hydrochloride on haemodynamics and regulators of circulation in patients undergoing major abdominal surgery

Background: Catecholaminergic support is often used to improve haemodynamics in patients undergoing major abdominal surgery. Dopexamine is a synthetic vasoactive catecholamine with beneficial microcirculatory properties. Methods: The influence of perioperative administration of dopexamine on cardiorespiratory data and important regulators of macro- and microcirculation were studied in 30 patients undergoing Whipple pancreaticduodenectomy. The patients received randomized and blinded either 2 μg · kg^?1 · min^?1 of dopexamine (n=15) or placebo (n=15, control group). The infusion was started after induction of anaesthesia and continued until the morning of the first postoperative day. Endothelin-1 (ET-1), vasopressin, atrial natriuretic peptide (ANP), and catecholamine plasma levels were measured from arterial blood samples. Measurements were carried out after induction of anaesthesia, 2 h after onset of surgery, at the end of surgery, 2 h after surgery, and on the morning of the first postoperative day. Results: Cardiac index (CI) increased significantly in the dopexamine group (from 2.61±0.41 to 4.57±0.78 1 · min^?1 · m^?2) and remained elevated until the morning of the first postoperative day. Oxygen delivery index (DO₂I) and oxygen consumption index (VO₂I) were also significantly increased in the dopexamine group (DO₂I: from 416±91 to 717±110 ml/m² · m²; VO₂I: from 98±25 to 157±22 ml/m² · m²), being significantly higher than in the control group. pHi remained stable only in the dopexamine patients, indicating adequate splanchnic perfusion. Vasopressive regulators of circulation increased significantly only in the untreated control patients (vasopressin: from 4.37±1.1 to 35.9±12.1 pg/ml; ET-1: from 2.88±0.91 to 6.91±1.20 pg/ml). Conclusion: Patients undergoing major abdominal surgery may profit from prophylactic perioperative administration of dopexamine hydrochloride in the form of improved haemodynamics and oxygenation as well as beneficial influence on important regulators of organ blood flow.     

Systemic analgesia adapted to the children's condition

A concept of balanced analgesia using nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), opioids, and corticosteroids can also be used in patients with pre-existing illnesses. NSAIDs are the most effective treatment for acute pain of moderate intensity in children; however, these drugs should be avoided in patients at increased risk for serious side effects, e.g. patients with renal impairment, bleeding tendency, or extreme prematurity. NSAIDs can be given with minimal risks to the younger child with mild to moderate asthma, and, in these patients, the use of steroids can be encouraged; in addition to their antiemetic and analgesic action, a beneficial effect on asthma symptoms can be expected. In the non-intubated child with cerebral trauma, exaggerated sedation caused by opioids and increased bleeding tendency caused by NSAIDs must be avoided. In neonates and small infants, the oral administration of sucrose or glucose is helpful to minimize pain reaction during short uncomfortable interventions.     

A comparison of the inhibitory effects of four volatile anaesthetics on the metabolism of chlorzoxazone, a substrate for CYP2E1, in rabbits

Background: Halothane inhibits in vitro and in vivo activity of cytochrome P-450 (CYP) 2E1. There are several fluorinated volatile anaesthetics besides halothane, and most of them are defluorinated by CYP2E1. It is unclear whether other fluorinated anaesthetics inhibit the in vivo activity of CYP2E1.
Methods: We compared the inhibitory effects of therapeutic concentrations of four inhalational anaesthetics, halothane, enflurane, isoflurane, and sevoflurane, on chlorzoxazone metabolism in rabbits receiving artificial ventilation.
Results: All four inhalational anaesthetics decreased arterial blood pressure and increased plasma chlorzoxazone concentration. However, no significant differences in the plasma chlorzoxazone concentration were found between the four anaesthetics. The estimated chlorzoxazone clearance increased after beginning inhalation with all four agents, but no significant difference in clearance was noted between agents.
Conclusions: At therapeutic concentrations, the in vivo inhibitory effect on chlorzoxazone metabolism was similar for all four inhalational anaesthetics examined, even though their chemical characteristics and extent of hepatic metabolism differ considerably.